|
⚲
|
| NGN Biomed 2A | |
|---|---|
| Firm |
NGN Capital LLC
✚
|
| Fund # | 805-8873822956 |
| CIK # | 0001422818 |
| Sale | 2007-12-14 ($350.0 M Offered, $173.2 M Sold) |
| Fund | Venture Capital Fund |
| Phone | 2129720077 |
| Address | 369 Lexington Ave, 17th Floor New York, 10017 |
| Source | [EDGAR] [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | NGN Biomed II GP LP |
| Custodian | |
| Auditor | Grant Thornton LLP, RSM US LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2010-03-11 (D/A) |
| Exemption | 506, 3(c), 3(c)(1) |
| Remaining | $176,750,000 |
| Duration | More than one year |
| Net Assets | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| NGN Biomed II GP LP | Promoter | |
| NGN Capital LLC | Promoter |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Armada Capital LLC
✚
|
0.1 | |
|
Pichardo Asset Management Sa de CV
✚
|
0.1 | |
|
Aldemar Research Corporation
✚
|
0.1 | |
|
Designer Technologies Inc
✚
|
0.1 | |
|
Orchard Advisors LLC
✚
|
0.1 | |
|
SHFP LLC
✚
|
0.1 | |
|
Heritage Grove Wealth Management LLC
✚
|
0.1 | |
|
Shankland Financial Advisors LLC
✚
|
0.1 | |
|
Orasis Capital
✚
|
0.1 | |
|
Sterling Asset Management Co Inc
✚
|
0.1 |